Republic Bancorp (NASDAQ:RBCAA) reported quarterly earnings of $0.91 per share. This is a 7.14 percent decrease over earnings of $0.98 per share from the same period last year.
Citigroup Initiates Coverage On Ascendis Pharma with Buy Rating, Announces Price Target of $187
Citigroup analyst David Lebowitz initiates coverage on Ascendis Pharma (NASDAQ:ASND) with a Buy rating and announces Price Target of $187.